BTX - BioTime, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-3,4585,9237,036
Cost of Revenue-1683581,107
Gross Profit-3,2905,5655,929
Operating Expenses
Research Development-24,02436,10642,604
Selling General and Administrative-19,92228,42629,134
Non Recurring----
Total Operating Expenses-44,11464,89072,845
Operating Income or Loss--40,656-58,967-65,809
Income from Continuing Operations
Total Other Income/Expenses Net-17,36777,5883,159
Earnings Before Interest and Taxes--40,656-58,967-65,809
Interest Expense-189-792-1,047-440
Income Before Tax--23,28918,621-62,650
Income Tax Expense----4,516
Minority Interest-1,62212,58050,631
Net Income From Continuing Ops--23,28918,621-58,134
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--19,97633,572-46,991
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--19,97633,572-47,406